Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL
Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM
Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Partner
Lundbeckfond Ventures - Copenhagen, Denmark
Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM

More Jobs >>

Events

New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami

More Events >>

Related Tags >> Vaccine Merck

Ireland News

Most Popular Ireland Story

Merck starts work on vax R&D center

November 6, 2008 — 8:29am ET | By John Carroll

Merck is preparing to launch construction of a €200 million vaccine R&D facility in the southeastern area of Ireland. The pharma giant says that construction will get started next year and Read more...

Ireland Press Releases

Elsevier Launches SciVal Funding App on SciVerse Applications
Research and Markets: Innovation Case Study: American Cancer Society - How Does This Organization Apply Innovation to Help
Actavis launches its business in Ireland
Millipore Corporation Opens $83M Facility Overseas
PRESS RELEASE: Amgen to postpone indefinitely plans for a manufacturing facility in Ireland

Latest Headlines

Merck starts work on vax R&D center
November 6, 2008

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK